Literature DB >> 32322969

Effects of synbiotic consumption on lipid profile: a systematic review and meta-analysis of randomized controlled clinical trials.

Amir Hadi1, Ehsan Ghaedi2,3, Saman Khalesi4, Makan Pourmasoumi5, Arman Arab6.   

Abstract

BACKGROUND AND AIMS: Existing evidence on the possible effects of synbiotics on lipid profile is inconclusive. The aim of the present systematic review was to clarify the effects of synbiotics consumption on lipid profile.
METHODS: A systematic literature search of online databases PubMed, Scopus, ISI Web of science, Cochrane's library and Google Scholar was conducted up to January 2019. Randomized controlled trials (RCTs) investigating the effects of synbiotics on lipid profile in adults were included. The overall effect was presented as weighted mean difference (WMD) and 95% confidence interval (CI) in a random-effects meta-analysis model.
RESULTS: A total of 23 RCTs with 1338 participants were included. Synbiotic consumption resulted in a significant decrease in plasma concentrations of total cholesterol (WMD = - 10.17 mg/dL; 95% CI - 15.74 to - 4.60; p < 0.001), triglyceride (WMD = - 14.30 mg/dL; 95% CI - 25.32 to - 3.28; p = 0.01), low-density lipoprotein cholesterol (WMD  = - 8.32 mg/dL; 95% CI - 13.21 to - 3.43; p < 0.001), and an increase in plasma high-density lipoprotein cholesterol (WMD = 1.3 mg/dL; 95% CI 0.03 to 2.56; p = 0.04) levels compared to control (placebo supplements/control foods/conventional products). The effects are more pronounced when synbiotics supplements are consumed for > 8 weeks.
CONCLUSION: Synbiotic supplements may be beneficial to improve lipid profile, especially when they are consumed for > 8 weeks.

Entities:  

Keywords:  Cholesterol; Lipid profile; Meta-analysis; Synbiotics; Triglyceride

Mesh:

Substances:

Year:  2020        PMID: 32322969     DOI: 10.1007/s00394-020-02248-7

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  37 in total

Review 1.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Christopher P Day; Enzo Bonora
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

2.  Variance imputation for overviews of clinical trials with continuous response.

Authors:  D Follmann; P Elliott; I Suh; J Cutler
Journal:  J Clin Epidemiol       Date:  1992-07       Impact factor: 6.437

3.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Int J Surg       Date:  2010-02-18       Impact factor: 6.071

4.  Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

Authors:  John B Buse; Henry N Ginsberg; George L Bakris; Nathaniel G Clark; Fernando Costa; Robert Eckel; Vivian Fonseca; Hertzel C Gerstein; Scott Grundy; Richard W Nesto; Michael P Pignone; Jorge Plutzky; Daniel Porte; Rita Redberg; Kimberly F Stitzel; Neil J Stone
Journal:  Circulation       Date:  2006-12-27       Impact factor: 29.690

5.  Effects of physical activity on risk factors for coronary heart disease in previously sedentary women: a five-year longitudinal study.

Authors:  A W Sedgwick; A H Davidson; R E Taplin; D W Thomas
Journal:  Aust N Z J Med       Date:  1988-06

6.  Dietary modulation of the human colonic microbiota: updating the concept of prebiotics.

Authors:  Glenn R Gibson; Hollie M Probert; Jan Van Loo; Robert A Rastall; Marcel B Roberfroid
Journal:  Nutr Res Rev       Date:  2004-12       Impact factor: 7.800

7.  Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium.

Authors:  David C Goff; Alain G Bertoni; Holly Kramer; Denise Bonds; Roger S Blumenthal; Michael Y Tsai; Bruce M Psaty
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690

Review 8.  Gut microbiota and obesity.

Authors:  Philippe Gérard
Journal:  Cell Mol Life Sci       Date:  2015-10-12       Impact factor: 9.261

Review 9.  Dysbiosis in gastrointestinal disorders.

Authors:  Christopher Chang; Henry Lin
Journal:  Best Pract Res Clin Gastroenterol       Date:  2016-02-16       Impact factor: 3.043

10.  Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease.

Authors:  Saba Sayari; Hassan Neishaboori; Maryam Jameshorani
Journal:  Clin Mol Hepatol       Date:  2018-06-12
View more
  2 in total

Review 1.  The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease.

Authors:  Rima Mohsen Chakaroun; Lisa M Olsson; Fredrik Bäckhed
Journal:  Nat Rev Cardiol       Date:  2022-10-14       Impact factor: 49.421

Review 2.  Gut microbiota and old age: Modulating factors and interventions for healthy longevity.

Authors:  Vasile Coman; Dan Cristian Vodnar
Journal:  Exp Gerontol       Date:  2020-09-23       Impact factor: 4.032

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.